Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Izotropic Corp
(CSE:
IZO
)
0.2850
UNCHANGED
Streaming Delayed Price
Updated: 3:54 PM EST, Feb 4, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.2850
Bid (Size)
0.2800 (12,000)
Ask (Size)
0.3150 (5,000)
Prev. Close
0.2850
Today's Range
0.2850 - 0.2850
52wk Range
0.0350 - 0.4700
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Small Cap Growth Virtual Investor Conference Agenda Announced for February 6th
February 04, 2025
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Izotropic to Present at Investor Conference February 6th
February 03, 2025
From
Virtual Investor Conferences
Via
GlobeNewswire
Performance
YTD
+185.00%
+185.00%
1 Month
+159.09%
+159.09%
3 Month
+375.00%
+375.00%
6 Month
+185.00%
+185.00%
1 Year
+147.83%
+147.83%
More News
Read More
Izotropic Files Pre-Submission with U.S. FDA for Breast Cancer Screening
January 09, 2025
Via
Newsfile
Exposures
Product Safety
Izotropic Provides Regulatory and Operational Updates
January 08, 2024
Via
TheNewswire.com
Exposures
Product Safety
Izotropic Announces AGM Results
December 22, 2023
Via
TheNewswire.com
Izotropic Completes Pre-Submission Meeting With U.S. FDA
November 01, 2023
Via
TheNewswire.com
Exposures
Product Safety
Izotropic Confirms FDA Pre-Submission Meeting Date
September 27, 2023
Via
TheNewswire.com
Exposures
Product Safety
Izotropic Closes Non-Brokered Private Placement
September 20, 2023
Via
TheNewswire.com
Izotropic Corporation Announces Non-Brokered Private Placement
September 13, 2023
Via
TheNewswire.com
Izotropic Files Class II Pre-Submission with FDA & Releases Details on Predicate Devices
September 06, 2023
Via
TheNewswire.com
Exposures
Product Safety
Izotropic Engages Market Awareness Consultant
June 27, 2023
Via
TheNewswire.com
Izotropic Modifies Market Approval Pathway & Strategy
June 20, 2023
Via
TheNewswire.com
Exposures
Product Safety
Izotropic Completes QSUB Meeting With FDA Regarding Clinical Study Acceleration
May 15, 2023
Via
TheNewswire.com
Exposures
Product Safety
Izotropic Provides Business Update
April 27, 2023
Via
TheNewswire.com
Izotropic to Extend Period for Unsecured Loans
March 29, 2023
Via
TheNewswire.com
Izotropic's Izoview Breast CT Device to be Featured on Advancements TV Show in USA
January 13, 2023
Via
TheNewswire.com
Izotropic Creates Compensation Committee and Adopts Charter
January 12, 2023
Via
TheNewswire.com
Izotropic Releases First Video of IzoView
January 09, 2023
Via
Newsfile
Izotropic Releases First Video of Izoview
January 09, 2023
Via
TheNewswire.com
Izotropic Reports Board Meeting Results
January 04, 2023
Via
TheNewswire.com
Izotropic Delays Announcements to 2023, Holds Board Meeting
December 28, 2022
Via
TheNewswire.com
Izotropic Announces 2022 AGM Results and Clarifies Restating of Financial Statements
December 20, 2022
Via
TheNewswire.com
Izotropic Completes Izoview Development and Assembly, Prepares for Final Testing
December 01, 2022
Via
TheNewswire.com
Alexander Tokman Joins Izotropic Board Of Directors
November 11, 2022
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
IZOTROPIC CORPORATION Announces Closing of Non-Brokered Private Placement
November 10, 2022
Via
TheNewswire.com
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
